Conotoxin therapeutics: a pipeline for success?
- 1 April 2007
- journal article
- Published by Informa Healthcare in Expert Opinion on Drug Discovery
- Vol. 2 (4) , 453-468
- https://doi.org/10.1517/17460441.2.4.453
Abstract
The pharmacopoeia of conotoxins from the marine snail Conus has evolved with time, providing a myriad of molecular scaffolds on which critical, molecular pharmacophoric descriptors, responsible for mediating conotoxin receptor-target specificity and selectivity have been grafted. Several reports have defined how these critical determinants contribute to refined, subtype-selective receptor recognition. However, the clinical utility of conotoxins is debatable with a single conotoxin, ω-MVIIA (ziconotide), approved by the US FDA. The authors review the present status of conotoxin-based drug discovery efforts, highlighting ongoing preclinical and clinical studies, while discussing strategies that may be necessary to overcome the barriers inherent to peptide therapeutics. Through the beauty of nature and the art of design it should be possible to expand the Conus pipeline.Keywords
This publication has 138 references indexed in Scilit:
- Terphenyl-Based Bak BH3 α-Helical Proteomimetics as Low-Molecular-Weight Antagonists of Bcl-xLJournal of the American Chemical Society, 2005
- Total chemical synthesis and NMR characterization of the glycopeptide tx5a, a heavily post‐translationally modified conotoxin, reveals that the glycan structure is α‐d‐Gal‐(1→3)‐α‐d‐GalNAcEuropean Journal of Biochemistry, 2004
- Isolation and characterization of three novel Gla-containing Conus marmoreus venom peptides, one with a novel cysteine patternBiochemical and Biophysical Research Communications, 2004
- Small-molecule inhibitors of protein–protein interactions: progressing towards the dreamNature Reviews Drug Discovery, 2004
- α‐Conotoxins EpI and AuIB switch subtype selectivity and activity in native versus recombinant nicotinic acetylcholine receptorsFEBS Letters, 2003
- Powerful antinociceptive effects of the cone snail venom-derived subtype-selective NMDA receptor antagonists conantokins G and TPain, 2003
- Contryphan-Vn: A Novel Peptide from the Venom of the Mediterranean Snail Conus ventricosusBiochemical and Biophysical Research Communications, 2001
- Structural Elements in α-Conotoxin ImI Essential for Binding to Neuronal α7 ReceptorsJournal of Biological Chemistry, 1998
- Three-Dimensional Structure of a γ-Carboxyglutamic Acid-Containing Conotoxin, Conantokin G, from the Marine SnailConus geographus: The Metal-Free Conformer,Biochemistry, 1997
- Use of a Dipeptide Chemical Library in the Development of Non-Peptide Tachykinin NK3Receptor Selective AntagonistsJournal of Medicinal Chemistry, 1996